Together with already large pharmaceutical markets such as Japan, it is not difficult to see why Asia represents a block of great interest to global pharmaceutical giants. But what of the biotechnology industry? Should it participate moreactively as Asia develops? Can it afford not to? This article addresses issues to consider for biotechnology companies contemplating an Asia strategy as part of planning product development.
노보텍, BIO 2023 APAC Summit 행사 및 바이오테크 분야에서 중국과의 관계 구축에 관한 Endpoints 패널 후원
미국, 매사추세츠주 보스턴 - 아시아 태평양 중심의 선도적인 바이오텍CRO인 노보텍은 BIO 202Read more